Direxion Daily S&P Biotech Bull 3x Shares Rating $69.34 +0.22 (+0.32%) Closing price 08/14/2025 04:10 PM EasternExtended Trading$69.68 +0.34 (+0.49%) As of 06:21 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.66Holdings in LABU have an aggregate rating of Moderate Buy based on 400 analyst ratings issued in the past year covering 19 companies (29.1% of the portfolio).LABU Aggregate Price Target$69.34High Prediction$69.34Average Prediction$69.34Low Prediction$69.34Holdings in LABU have an aggregate price target of $69.34 and a range of $69.34 to $69.34 covering 19 companies (29.1% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.73%MRNAModerna$26.69-0.7%4.4074 of 5 stars2.04$43.59 63.3%241.62%ALNYAlnylam Pharmaceuticals$442.73+2.4%4.2617 of 5 stars2.85$403.92 -8.8%27Positive News1.62%EXELExelixis$38.47-0.1%4.9091 of 5 stars2.55$44.06 14.5%22Positive NewsAnalyst Forecast1.61%HALOHalozyme Therapeutics$65.54+0.6%4.5816 of 5 stars2.18$66.56 1.5%11Positive NewsInsider Trade1.61%NBIXNeurocrine Biosciences$131.31-0.2%4.8663 of 5 stars2.86$160.90 22.5%22Positive News1.61%UTHRUnited Therapeutics$312.06+0.8%4.9352 of 5 stars2.69$382.00 22.4%13Positive NewsAnalyst Forecast1.60%INSMInsmed$127.75+4.0%4.0303 of 5 stars2.94$129.57 1.4%16Trending NewsAnalyst ForecastGap Up1.58%REGNRegeneron Pharmaceuticals$565.97+0.8%4.8423 of 5 stars2.76$829.65 46.6%25Positive NewsDividend AnnouncementAnalyst Forecast1.55%VRTXVertex Pharmaceuticals$390.30-1.4%4.9436 of 5 stars2.56$497.10 27.4%27Positive News1.53%AMGNAmgen$290.29+0.3%4.6686 of 5 stars2.33$303.76 4.6%21Trending NewsAnalyst Revision1.53%BMRNBioMarin Pharmaceutical$58.00-0.5%4.9979 of 5 stars2.75$93.17 60.6%24Positive News1.51%INCYIncyte$86.16+0.4%4.5634 of 5 stars2.33$81.20 -5.8%181.50%GILDGilead Sciences$119.02-0.9%4.8606 of 5 stars2.80$114.82 -3.5%25Positive NewsDividend AnnouncementAnalyst Revision1.49%ABBVAbbVie$204.78+1.6%4.7389 of 5 stars2.93$214.95 5.0%27Trending NewsAnalyst ForecastInsider Trade1.45%BIIBBiogen$134.94-0.2%4.8712 of 5 stars2.34$185.74 37.6%32Analyst Forecast1.44%EXASExact Sciences$44.99+0.2%4.8585 of 5 stars2.92$67.43 49.9%24Positive NewsAnalyst Forecast1.44%BBIOBridgeBio Pharma$51.18+1.6%4.368 of 5 stars3.00$61.35 19.9%17Insider Trade1.33%NTRANatera$158.44+0.5%3.2216 of 5 stars3.06$193.87 22.4%171.32%MDGLMadrigal Pharmaceuticals$371.37-0.6%3.7021 of 5 stars2.88$439.71 18.4%8Analyst ForecastInsider Trade This page (NYSEARCA:LABU) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access